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Over the past several years, the prevalence of human 
disease  caused  by  nontuberculous  mycobacteria  (NTM) 
has increased. Whether the increase in cases is real or 
whether more cases are being recognized remains unclear. 
Despite a considerable increase in knowledge about NTM 
infections, they still represent a diagnostic and therapeutic 
challenge for several reasons: 1) pathogenic isolates may 
be indistinguishable from contaminant or saprophytic iso-
lates; 2) timely and reliable identification of isolates may 
depend on proper communication between clinicians and 
laboratory staff; 3) lack of standardized susceptibility test-
ing makes adoption of tailored therapies unrealistic; and 4) 
lack of treatment guidelines exposes patients to toxic drugs 
and disappointing outcomes. Laboratory research and mul-
ticenter controlled trials are needed to improve diagnosis 
and treatment of these infections.
T
he >120 recognized species of nontuberculous myco-
bacteria (NTM) share common features: 1) they are 
facultative  pathogens;  2)  evidence  of  human-to-human 
transmission is lacking; 3) some NTM species are ubiqui-
tous and others have more restricted distribution; 4) treat-
ment may be difficult and vary according to the involved 
organism and disease site; and 5) pathogenesis is still un-
defined, depending on the interaction between the micro-
organism and the host’s immune system (1). About 90% 
of cases involve the pulmonary system; the rest involve 
lymph nodes, skin, soft tissues, and bones. Less frequently 
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Learning Objectives
Upon completion of this activity, participants will be able to:
Diagnose and treat nontuberculous mycobacterial (NTM) lymphadenitis effectively •	
Identify elements of NTM osteoarticular infections •	
Treat NTM skin infections according to standards of care •	
Describe infections with rapidly growing mycobacteria •	
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Activity Evaluation
1. Which of the following statements about nontuberculous 
mycobacterial (NTM) lymphadenitis is most accurate?
A.		 It	is	the	most	common	NTM	disease	in	children
B.		 The	most	frequently	isolated	organism	is	Mycobacterium 
haemophilum
C.		 	NTM	adenitis	almost	always	presents	with	the	sudden	onset	
of	severe	illness
D.		 Chemotherapy	is	more	effective	than	surgical	excision	for	
uncomplicated	NTM	lymphadenitis
2. Which of the following statements about osteoarticular 
infections with NTM is most accurate?
A.		 NTM	are	usually	spread	through	the	blood	to	the	bones	and	
joints
B.		 The	ankle	is	the	most	common	anatomic	location	of	NTM	
tenosynovitis
C.		 The	clinical	presentation	for	NTM	and	tuberculous	
osteoarticular	infections	is	very	similar
D.		 Chemotherapy	is	unnecessary	when	surgical	debridement	is	
used	to	treat	osteoarticular	infections	with	NTM
3. Which of the following treatments is appropriately matched 
with its NTM skin or soft tissue infection?
A.	 Mycobacterium marinum:	Doxycycline	monotherapy	is	
acceptable	for	severe	infection
B.		 Mycobacterium ulcerans:	Clarithromycin	is	the	treatment	of	
choice
C.		 M. ulcerans:	Minocycline	is	the	treatment	of	choice
D.		 M.	avium	complex:	Treatment	usually	consists	of	3	antibiotics	
for	6–12	months
4. Which of the following statements about rapidly growing 
mycobacteria (RGM) is most accurate?
A.		 They	respond	to	sterilization	with	formaldehyde	solutions	
only
B.		 They	include	organisms,	such	as	Mycobacterium fortuitum 
and	Mycobacterium chelonae
C.		 Symptoms	of	RGM	always	occur	within	4	weeks	of	exposure
D.		 The	usual	duration	of	antibiotic	therapy	for	infection	with	
RGM	is	1–2	months
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2. The material was organized clearly for learning to occur.
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3. The content learned from this activity will impact my practice.
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